MUC2

[키워드] analyzed Antwerp association AUC Baricitinib Blood Clinical outcome component correlated Course COVID-19 COVID-19 patient COVID-19 symptoms COVID-19 treatment Critical Critical case critical cases Critically ill critically ill COVID-19 patients diagnosing difference disease drug ENhance epithelial cells expression expression profile Favipiravir foundation healthy control healthy controls induce Innate immunity investigated lung tissue management Mild mild case mild cases Molecular biology Mortality mRNA mRNA expression MUC1 MUC13 MUC16 MUC2 MUC20 MUC21 MUC4 MUC6 mucin mucins Organ failure overexpression parameters Patient patients with COVID-19 patients without COVID-19 pulmonary epithelial cells Remdesivir respiratory Respiratory Support ROC RT-PCR assays SARS-COV-2 infection secondary infections Sensitivity and specificity severity suppress symptomatic symptomatic COVID-19 symptomatic patient Symptomatic patients Symptoms Tocilizumab transcriptional Treatment university with COVID-19
[DOI] 10.1172/jci.insight.151777 PMC 바로가기 [Article Type] Clinical Medicine